Is bortezomib active in patients with mantle cell lymphoma?

被引：0
|
作者：
Ludwig, Heinz [1 ]
机构：
[1] Wilhelminenspital Stadt Wien, Dept Med 1, Ctr Oncol & Haematol, A-1171 Vienna, Austria
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 05期
关键词：
bortezomib; mantle cell lymphoma; response; toxicity;
D O I：
10.1038/ncponc0789
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [41] A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
    Holkova, Beata
    Perkins, Edward B.
    Sokol, Lubomir
    Richards, Kristy L.
    Parekh, Samir
    Elstrom, Rebecca
    Badros, Ashraf Z.
    Espinoza-Delgado, Igor
    Schell, Michael J.
    Kimball, Amy
    Tombes, Mary Beth
    Shrader, Ellen
    Sankala, Heidi
    Coppola, Domenico
    Kmieciak, Maciej
    Sullivan, Daniel
    Roberts, John D.
    Grant, Steven
    BLOOD, 2011, 118 (21) : 353 - 354
  • [42] A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
    Yazbeck, Victor
    Shafer, Danielle
    Perkins, Edward B.
    Coppola, Domenico
    Sokol, Lubomir
    Richards, Kristy L.
    Shea, Thomas
    Ruan, Jia
    Parekh, Samir
    Strair, Roger
    Flowers, Christopher
    Morgan, David
    Kmieciak, Maciej
    Bose, Prithviraj
    Kimball, Amy
    Badros, Ashraf Z.
    Baz, Rachid
    Lin, Hui-Yi
    Zhao, Xiuhua
    Reich, Richard R.
    Tombes, Mary Beth
    Shrader, Ellen
    Sankala, Heidi
    Roberts, John D.
    Sullivan, Daniel
    Grant, Steven
    Holkova, Beata
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : 569 - +
  • [43] Infections in patients with mantle cell lymphoma
    Abalo, Kossi D.
    Ekberg, Sara
    Andersson, Therese M. L.
    Pahnke, Simon
    Albertsson-Lindblad, Alexandra
    Smedby, Karin E.
    Jerkeman, Mats
    Glimelius, Ingrid
    HEMASPHERE, 2024, 8 (07):
  • [44] Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells
    Milani, Valeria
    Lorenz, Monika
    Weinkauf, Marc
    Rieken, Malte
    Pastore, Alessandro
    Dreyling, Martin
    Issels, Rolf
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2009, 25 (04) : 262 - 272
  • [45] MUM1 is a Potential Marker of Bortezomib Resistance in Mantle Cell Lymphoma
    Patel, Sanjay
    Eickhoff, Jens
    Salama, Mohamed E.
    Shaw, Gene
    Kahl, Brad
    Yang, David T.
    LABORATORY INVESTIGATION, 2016, 96 : 367A - 367A
  • [46] Bortezomib resistant constitutive NF-κB activation in mantle cell lymphoma
    Yang, David T.
    Young, Ken H.
    Kahl, Brad S.
    Miyamoto, Shigeki
    BLOOD, 2007, 110 (11) : 1015A - 1015A
  • [47] Fludarabine, Bortezomib, Myocet® and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma
    Orciuolo, Enrico
    Buda, Gabriele
    Pelosini, Matteo
    Petrini, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (05) : 810 - 812
  • [48] Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
    Robak, Tadeusz
    Huang, Huiqiang
    Jin, Jie
    Zhu, Jun
    Liu, Ting
    Samoilova, Olga
    Pylypenko, Halyna
    Verhoef, Gregor
    Siritanaratkul, Noppadol
    Osmanov, Evgenii
    Alexeeva, Julia
    Pereira, Juliana
    Drach, Johannes
    Mayer, Jiri
    Hong, Xiaonan
    Okamoto, Rumiko
    Pei, Lixia
    Rooney, Brendan
    van de Velde, Helgi
    Cavalli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10): : 944 - 953
  • [49] Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program
    Galan, Patricia Perez
    Jensen, Helena Mora
    Weniger, Marc A.
    Chapman, Colby M.
    Liu, Poching
    Raghavachari, Nalini
    Shaffer, Arthur L., III
    Staudt, Louis M.
    Wiestner, Adrian
    BLOOD, 2009, 114 (22) : 121 - 121
  • [50] MUM1 is a Potential Marker of Bortezomib Resistance in Mantle Cell Lymphoma
    Patel, Sanjay
    Eickhoff, Jens
    Salama, Mohamed E.
    Shaw, Gene
    Kahl, Brad
    Yang, David T.
    MODERN PATHOLOGY, 2016, 29 : 367A - 367A
12345